bioRxivMicrobiologyPreprint
A truncated SARS-CoV-2 nucleocapsid protein enhances virus fitness by evading antiviral responses
Rory P. MulloyiD, Danyel EvseeviD, Maxwell P. Bui-MarinosiD, Noga Sharlin, Jennifer A. CorcoraniD
Abstract
Viruses face a selective pressure to evade cellular antiviral responses to control the outcome of an infection. However, due to their limited genome size, viruses must adopt unique strategies to confront cellular sensors. Since emerging in humans, SARS-CoV-2 has accrued multiple mutations throughout its genome, some of which enhanced virus replication and led to the rise of viral variants. However, the biological consequences of many of these changes remain to be discovered. Here, we show that SARS-CoV-2 produces a truncated form of the nucleocapsid protein, called N*M210. Due to the acquisition of a viral transcription regulatory sequence (TRS) in the N gene, certain variants, such as Omicron, produce a new viral mRNA that markedly increases N*M210 expression. We show that N*M210 is a dsRNA binding protein, which inhibits multiple arms of the cellular antiviral response, including blocking interferon induction and inhibiting stress granule formation. We created a panel of recombinant SARS-CoV-2 viruses (rSARS-2) with mutations in the N gene that increased or decreased N*M210 production. We show that N*M210 production increases virus fitness, as viruses that produce more N*M210 outcompeted wild-type rSARS-2. We demonstrate that the fitness advantage provided by N*M210 is partly due to its ability to potently block stress granules. We propose a model where, to evade the cellular antiviral response, SARS-CoV-2 has evolved a mechanism to increase the production of a truncated form of the N protein, which broadly limits the activation of dsRNA-induced antiviral responses, tipping the balance in favour of the virus in the battle for control of the cell. O_FIG O_LINKSMALLFIG WIDTH=173 HEIGHT=200 SRC="FIGDIR/small/638421v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@98766dorg.highwire.dtl.DTLVardef@186f69eorg.highwire.dtl.DTLVardef@1a903f4org.highwire.dtl.DTLVardef@142c799_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LISARS-CoV-2 variants evolved to upregulate truncated N (N*) synthesis to increase virus fitness C_LIO_LIN*M210 is a potent dsRNA-binding protein that blocks cellular dsRNA sensing C_LIO_LIN*M210 inhibits stress granule formation independent of G3BP1 binding C_LI
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 7
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mutations in SARS-CoV-2 Nsp1 are critical determinants of viral pathogenicity in mice
Nathaniel D. Jackson, Fuchun Zhou, … Luis Martínez‐Sobrido·bioRxiv·Aug 19, 2026
- Nucleocapsid 203 mutations enhance SARS-CoV-2 immune evasion
- Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesis.
R. Elias Alvarado, Jennifer Chen, … Vineet D. Menachery·bioRxiv·Jun 18, 2026
- SARS-CoV-2 Nucleocapsid protein attenuates stress granule formation and alters gene expression via direct interaction with host mRNAs
Syed Nabeel‐Shah, Hyunmin Lee, … Jack F. Greenblatt·iSciencePeer-reviewed·Dec 4, 2021
- Variant-specific nucleocapsid mutations shape host innate immune trajectories during SARS-CoV-2 infection
Julia M. Berger, Jonas Martin Schroeder, … Charlotte Uetrecht·bioRxiv·Sep 8, 2026
- Multiple layers of innate immune response antagonism of SARS-CoV-2
F. Zhou, S. Periasamy, … A. Bukreyev·bioRxiv·Jan 29, 2024